SCHEMBL459993

SCHEMBL459993

COc1cc(OC)c(Br)c(P(=O)(c2cc(C)cc(C)c2)c2cc(C)cc(C)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.38
ALDH1A1 P00352 4/20 0.33
CYP3A4 P08684 3/20 0.33
CYP1A2 P05177 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
MAPK1 P28482 2/20 0.33
TSHR P16473 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CRHR1 P34998 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
NQO2 P16083 2/20 0.32
CYP19A1 P11511 1/20 0.32
ACHE P22303 1/20 0.32
LMNA P02545 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
NPC1 O15118 1/20 0.31
AHR P35869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL459987 0.85 MAOB (0.34) MAOBALDH1A1CYP3A4CYP1A2TDP1
SCHEMBL458557 0.84 ALDH1A1 (0.41) ALDH1A1CYP3A4CYP1A2TDP1MAPK1
SCHEMBL458031 0.82 KMT2A (0.48) MAOBALDH1A1CYP1A2MEN1KMT2A
SCHEMBL459659 0.79 CA1 (0.34) MAOBALDH1A1CYP1A2TDP1TSHR
SCHEMBL457995 0.75 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP1A2TDP1MAPK1
SCHEMBL14337942 0.73 CYP3A4 (0.35) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL14337959 0.72
SCHEMBL15119997 0.72 PGK1 (0.34) ALDH1A1CYP3A4CYP1A2MAPK1LMNA
SCHEMBL14337977 0.72
SCHEMBL459755 0.71 POLB (0.38) MAOBALDH1A1CYP3A4CYP1A2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062085-B2 Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2015-06-23 US disclosed
US-20130184479-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2013-07-18 US disclosed
EP-2614069-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS Kanata Chemical Technologies Inc. (CA) 2013-07-17 EP disclosed
WO-2012031358-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184479-A1 BIARYL DIPHOSPHINE LIGANDS, INTERMEDIATES OF THE SAME AND THEIR USE IN ASYMMETRIC CATALYSIS AGPS, COASY, BLVRB MAOB 17/4885ALDH1A1 1187/4885CYP3A4 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.